FR2334347B1 - - Google Patents

Info

Publication number
FR2334347B1
FR2334347B1 FR7637076A FR7637076A FR2334347B1 FR 2334347 B1 FR2334347 B1 FR 2334347B1 FR 7637076 A FR7637076 A FR 7637076A FR 7637076 A FR7637076 A FR 7637076A FR 2334347 B1 FR2334347 B1 FR 2334347B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7637076A
Other languages
French (fr)
Other versions
FR2334347A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FR2334347A1 publication Critical patent/FR2334347A1/fr
Application granted granted Critical
Publication of FR2334347B1 publication Critical patent/FR2334347B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66Methanesulfonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
FR7637076A 1975-12-09 1976-12-09 Acides et esters aryloxyalcoylaminobenzoiques, leur preparation et leurs applications, notamment comme hypolipidemiques Granted FR2334347A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63901875A 1975-12-09 1975-12-09

Publications (2)

Publication Number Publication Date
FR2334347A1 FR2334347A1 (fr) 1977-07-08
FR2334347B1 true FR2334347B1 (pl) 1980-10-31

Family

ID=24562393

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7637076A Granted FR2334347A1 (fr) 1975-12-09 1976-12-09 Acides et esters aryloxyalcoylaminobenzoiques, leur preparation et leurs applications, notamment comme hypolipidemiques

Country Status (22)

Country Link
JP (1) JPS5273834A (pl)
AR (1) AR214187A1 (pl)
AT (1) AT358013B (pl)
AU (1) AU507077B2 (pl)
BE (1) BE849231A (pl)
BG (1) BG27540A3 (pl)
CS (1) CS199283B2 (pl)
DD (1) DD128354A5 (pl)
DE (1) DE2654646A1 (pl)
DK (1) DK550676A (pl)
ES (1) ES454073A1 (pl)
FR (1) FR2334347A1 (pl)
GB (1) GB1533647A (pl)
IL (1) IL50926A (pl)
IN (1) IN145203B (pl)
NL (1) NL7613696A (pl)
PL (1) PL109985B1 (pl)
PT (1) PT65945B (pl)
RO (1) RO71276A (pl)
SE (1) SE7613808L (pl)
SU (1) SU636225A1 (pl)
ZA (1) ZA766847B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207855D0 (en) * 1992-04-09 1992-05-27 Ici Plc Therapeutic amines
US5741926A (en) * 1997-02-12 1998-04-21 Shaman Pharmaceuticals, Inc. Aniline derivatives having antihyperglycemic activity

Also Published As

Publication number Publication date
SE7613808L (sv) 1977-06-10
PT65945B (en) 1978-06-14
AU1983176A (en) 1978-05-25
CS199283B2 (en) 1980-07-31
RO71276A (ro) 1982-10-26
SU636225A1 (ru) 1978-12-05
IL50926A (en) 1980-12-31
PL109985B1 (en) 1980-06-30
IN145203B (pl) 1978-09-09
DD128354A5 (de) 1977-11-16
ZA766847B (en) 1977-10-26
AU507077B2 (en) 1980-01-31
BE849231A (fr) 1977-06-09
PL194269A1 (pl) 1978-06-05
PT65945A (en) 1977-01-01
BG27540A3 (en) 1979-11-12
FR2334347A1 (fr) 1977-07-08
AT358013B (de) 1980-08-11
IL50926A0 (en) 1977-01-31
GB1533647A (en) 1978-11-29
ES454073A1 (es) 1978-02-16
AR214187A1 (es) 1979-05-15
DE2654646A1 (de) 1977-06-16
DK550676A (da) 1977-06-10
NL7613696A (nl) 1977-06-13
ATA907776A (de) 1980-01-15
JPS5273834A (en) 1977-06-21

Similar Documents

Publication Publication Date Title
FR2334347B1 (pl)
JPS5259883U (pl)
CH595989A5 (pl)
CH602464A5 (pl)
BG22245A1 (pl)
BG22434A1 (pl)
BG22506A1 (pl)
BG22902A1 (pl)
BG22950A1 (pl)
CH536275A4 (pl)
CH583647A5 (pl)
CH586541A5 (pl)
CH588681A5 (pl)
CH590459A5 (pl)
CH591438A5 (pl)
CH592890A5 (pl)
BE826796A (pl)
CH594132A5 (pl)
CH594218A5 (pl)
CH595058A5 (pl)
CH595263A5 (pl)
CH595421A5 (pl)
CH595435A5 (pl)
CH595562A5 (pl)
CH593320A5 (pl)

Legal Events

Date Code Title Description
ST Notification of lapse